Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01502709 · ClinicalTrials.gov registry record · NA
Neurostimulation in Temporomandibular Disorders (TMD) Patients
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01502709 is a NA study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 5 participants.
The verdict
NCT01502709, a NA study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The investigators propose to conduct a randomized blinded placebo-controlled clinical trial in patients with chronic TMD (N=20). Patients will be randomly assigned to receive either active treatment (caloric vestibular neurostimulation) or placebo. Data will be collected prior to and after treatment on thermal and mechanical pain thresholds, clinical signs and symptoms of TMD, and any adverse events.
Interventions
- DEVICE placebo
- DEVICE Caloric Vestibular Neurostimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01502709
The ClinicalTrials.gov registry entry for NCT01502709 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01502709 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01502709 about?
NCT01502709 is a clinical study titled "Neurostimulation in Temporomandibular Disorders (TMD) Patients". The investigators propose to conduct a randomized blinded placebo-controlled clinical trial in patients with chronic TMD (N=20). Patients will be randomly assigned to receive either active treatment (caloric vestibular neurostimulation) or placebo. Data will be collected prior to and after treatment...
What is the current status of trial NCT01502709?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2011-12. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01502709?
The interventions under investigation include: placebo (DEVICE), Caloric Vestibular Neurostimulation (DEVICE).
Who is sponsoring clinical trial NCT01502709?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.